Európai Unió -
izlandi -
EMA (European Medicines Agency)
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - blæðandi hiti, ebóla - bóluefni - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
alimemazin evolan hart hylki 20 mg
evolan pharma ab - alimemazinum tartrat - hart hylki - 20 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
alimemazin evolan dropar til inntöku, lausn 40 mg/ml
evolan pharma ab - alimemazinum tartrat - dropar til inntöku, lausn - 40 mg/ml
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
folsyra evolan tafla 5 mg
evolan pharma ab - folic acid - tafla - 5 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
hydrokortison evolan (hydrokorticon trimb) krem 10 mg/g
evolan pharma ab - hydrocortisonum inn - krem - 10 mg/g
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
midodrin evolan tafla 2,5 mg
evolan pharma ab - midodrinum hýdróklóríð - tafla - 2,5 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
midodrin evolan tafla 5 mg
evolan pharma ab - midodrinum hýdróklóríð - tafla - 5 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
melatonin evolan mixtúra, lausn 1 mg/ml
evolan pharma ab - melatoninum inn; sucralose - mixtúra, lausn - 1 mg/ml
Európai Unió -
izlandi -
EMA (European Medicines Agency)
zabdeno
janssen-cilag international n.v. - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - blæðandi hiti, ebóla - bóluefni - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
Európai Unió -
izlandi -
EMA (European Medicines Agency)
ervebo
merck sharp & dohme b.v. - skal læknir hafa blöðrum bólgur veira (álag indiana) með eyðingu umslagið glýkóprótein, komi með zaire ebolavirus (álag kikwit 1995) yfirborðið glýkóprótein - blæðandi hiti, ebóla - bóluefni - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. notkun ervebo ætti að vera í samræmi við opinbera tillögur.